The Changing Drug Landscape

This chapter examines the rising influence of xylazine and B-TEMPS in the illicit drug supply, discussing their impact on overdose rates and health risks. It highlights the challenges faced by policymakers in managing the evolving and increasingly dangerous drug market, characterized by the dominance of fentanyl and unregulated substances.